Related references
Note: Only part of the references are listed.Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure
Katarina Spiranec et al.
CIRCULATION (2018)
A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction
Takahiro Miyazaki et al.
CIRCULATION RESEARCH (2018)
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure
Reshma S. Baliga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity
Kazuhiro Nakao et al.
HYPERTENSION (2017)
C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
Jens Buttgereit et al.
CARDIOVASCULAR RESEARCH (2016)
Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C
Emmanuel E. Egom et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure
Estefania Tarazon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Endothelial C-type natriuretic peptide maintains vascular homeostasis
Amie J. Moyes et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study
Naveen L. Pereira et al.
PLOS ONE (2014)
Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors
John Azer et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
Fernando L. Martin et al.
PLOS ONE (2012)
Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes
S. Del Ry et al.
PEPTIDES (2011)
Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2
Michael Klaiber et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function
Suetonia C. Palmer et al.
HYPERTENSION (2009)
Pharmacologic therapies across the continuum of left ventricular dysfunction
William T. Abraham et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart
Silvia Del Ry et al.
PEPTIDES (2008)
Cardioprotective actions of peptide hormones in myocardial ischemia
Dwaine S. Burley et al.
HEART FAILURE REVIEWS (2007)
Differential regulation of membrane guanylyl cyclases in congestive heart failure: Natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriuretic peptide receptor in the failing heart
Deborah M. Dickey et al.
ENDOCRINOLOGY (2007)
Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice
Yong Wang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Cardiac production of C-type natriuretic peptide in heart failure
Silvia Del Ry et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B
TH Langenickel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity
S Del Ry et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide
K Sabrane et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction
T Socki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury - Novel cardioprotective role for endothelium-derived C-type natriuretic peptide
A Hobbs et al.
CIRCULATION (2004)
Effects of cardiac hormones on arterial pressure and sodium excretion in NPRA knockout mice
JR Dietz et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs
N Tamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor
RA Rose et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts
T Horio et al.
ENDOCRINOLOGY (2003)
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand et al.
CIRCULATION (2003)
Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor
SD Chauhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure
R Holtwick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
